Your browser doesn't support javascript.
loading
A simple procedure to identify children with B-lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single-point minimal residual disease measurement.
Popov, Alexander; Henze, Guenter; Roumiantseva, Julia; Budanov, Oleg; Belevtsev, Mikhail; Verzhbitskaya, Tatiana; Boyakova, Elena; Movchan, Liudmila; Tsaur, Grigory; Fadeeva, Maria; Lagoyko, Svetlana; Zharikova, Liudmila; Miakova, Natalia; Litvinov, Dmitry; Khlebnikova, Olga; Streneva, Olga; Stolyarova, Elena; Ponomareva, Natalia; Novichkova, Galina; Fechina, Larisa; Aleinikova, Olga; Karachunskiy, Alexander.
Affiliation
  • Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Belevtsev M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Verzhbitskaya T; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Boyakova E; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Movchan L; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Tsaur G; Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation.
  • Fadeeva M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Lagoyko S; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Zharikova L; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Khlebnikova O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Streneva O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Stolyarova E; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Ponomareva N; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Novichkova G; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Fechina L; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Aleinikova O; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Karachunskiy A; Republican Children's Hospital, Moscow, Russian Federation.
Pediatr Blood Cancer ; 70(6): e30295, 2023 06.
Article in En | MEDLINE | ID: mdl-36975157

Full text: 1 Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Burkitt Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Child / Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Burkitt Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Child / Humans Language: En Year: 2023 Type: Article